Login
Résultat de la recherche (1-20 par 30)Download
|
Symbol
|
QNGLTQ | QSCLTQ | WEVLTQ | RMASWV | RMASRV | XRMLTQ | AAUYSQ | RMBBNV | ABBZSQ | RMBWDV | Z095QZ | Z095SZ | ABJASQ | BTJBKB | ZPRLTQ | Z09D9Z | OCGRCH | EQKRCH | EQLRCH | RMAZBV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Reverse Convertible | Multi Vonti | Reverse Convertible | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Multi Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ABB LTD-REG ACCELLERON INDUSTRIES Ltd. / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé N / Roche GS / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Partners Group Hldg. AG / UBS Group AG | Roche GS / Swisscom / UBS | Nestlé / Novartis / Roche GS / UBS / Zurich | Autoneum Hldg. AG / Sandoz Group AG / UBS Group AG | Companie Financière Richemont SA / Sonova Hldg. AG / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | BASF SE / Lonza Group N / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Nestlé / Novartis / Roche GS / UBS / Zurich | Nestlé / Novartis / Roche GS / UBS / Zurich | Givaudan / Novartis AG / Roche AG / Sandoz Group AG / Sonova Hldg. AG / UBS Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
19.05.2025 | 03.12.2024 | 31.03.2028 | 10.02.2025 | 10.02.2026 | 06.07.2026 | 18.08.2025 | 17.11.2025 | 01.12.2025 | 27.07.2026 | 27.02.2025 | 28.02.2025 | 08.04.2027 | 08.04.2027 | 23.04.2027 | 09.04.2025 | 26.04.2027 | 22.05.2026 | 27.05.2026 | 28.05.2025 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
178,89 | 8,53 | 11,22 | 15,105 | 72,66 | 1 034,00 | 13,208 | 15,41 | 16,261 | 282,20 | 19,52 | 19,60 | 13,87 | 13,87 | 12,765 | 40,365 | 275,714 | 272,04 | 278,88 | 19,21 |
| rendement max. p.a. | 2,74% | -16,51% | 5,51% | 48,21% | - | - | 0,70% | 2,53% | 2,24% | 4,84% | 16,95% | 8,92% | 5,08% | 4,67% | 4,10% | 13,60% | 4,58% | 4,66% | 5,37% | 3,82% |
| Demande | 99,15 | 101,21 | 98,38 | 91,20 | 97,50 | 182,65 | 102,41 | 102,30 | 102,10 | 99,70 | 103,13 | 105,44 | 98,47 | 98,06 | 101,71 | 97,63 | 98,20 | 98,90 | 98,72 | 99,60 |
| Offre | 99,95 | 102,02 | 99,18 | 92,50 | - | 184,12 | 103,23 | 103,70 | 102,92 | 100,50 | 103,63 | 105,94 | 99,27 | 98,86 | 102,53 | 98,13 | 99,00 | 99,70 | 99,52 | 100,50 |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)